Showing results (111-120 of 10,913) with videos related to
Sort By:
Pageof 1,092
Oncology (Williston Park, N.Y.)|December 20, 2003
Risk models for neutropenia in patients with breast cancerChau T Dang, Monica N Fornier, Clifford A HudisJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publicationsR B Weiss, G G Gill, C A HudisAnnual Review of Medicine|January 15, 2015
Obesity and cancer: local and systemic mechanismsNeil M Iyengar, Clifford A Hudis, Andrew J DannenbergExpert Opinion on Pharmacotherapy|April 9, 2009
Therapeutic options for metastatic breast cancerPatrick G Morris, Heather L McArthur, Clifford A HudisJournal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendationsRobert W Carlson, Clifford A Hudis, Kathy I Pritchard, et al.Psychosomatic Medicine|November 1, 1992
An experimental analysis of classically conditioned nausea during cancer chemotherapyD H Bovbjerg, W H Redd, P B Jacobsen, et al.Indian Journal of Surgical Oncology|April 16, 2016
Erratum to: Obesity and Cancer: Concepts and ChallengesDaniel F Argolo, Neil M Iyengar, Clifford A HudisAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Obesity and inflammation: new insights into breast cancer development and progressionNeil M Iyengar, Clifford A Hudis, Andrew J DannenbergClinical Breast Cancer|July 9, 2013
Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancerAndrew D Seidman, Alison K Conlin, Ariadne Bach, et al.Oncology|October 1, 1994
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancerA D Seidman, L Norton, B S Reichman, et al.Pageof 1,092